145 related articles for article (PubMed ID: 15056469)
1. Neuroprotective mechanisms of creatine occur in the absence of mitochondrial creatine kinase.
Klivenyi P; Calingasan NY; Starkov A; Stavrovskaya IG; Kristal BS; Yang L; Wieringa B; Beal MF
Neurobiol Dis; 2004 Apr; 15(3):610-7. PubMed ID: 15056469
[TBL] [Abstract][Full Text] [Related]
2. Cerebral creatine kinase deficiency influences metabolite levels and morphology in the mouse brain: a quantitative in vivo 1H and 31P magnetic resonance study.
in 't Zandt HJ; Renema WK; Streijger F; Jost C; Klomp DW; Oerlemans F; Van der Zee CE; Wieringa B; Heerschap A
J Neurochem; 2004 Sep; 90(6):1321-30. PubMed ID: 15341516
[TBL] [Abstract][Full Text] [Related]
3. Creatine and cyclocreatine attenuate MPTP neurotoxicity.
Matthews RT; Ferrante RJ; Klivenyi P; Yang L; Klein AM; Mueller G; Kaddurah-Daouk R; Beal MF
Exp Neurol; 1999 May; 157(1):142-9. PubMed ID: 10222117
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of arundic acid, an astrocyte-modulating agent, in mouse brain against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity.
Himeda T; Kadoguchi N; Kamiyama Y; Kato H; Maegawa H; Araki T
Neuropharmacology; 2006 Mar; 50(3):329-44. PubMed ID: 16303147
[TBL] [Abstract][Full Text] [Related]
5. Altered brain phosphocreatine and ATP regulation when mitochondrial creatine kinase is absent.
Kekelidze T; Khait I; Togliatti A; Benzecry JM; Wieringa B; Holtzman D
J Neurosci Res; 2001 Dec; 66(5):866-72. PubMed ID: 11746413
[TBL] [Abstract][Full Text] [Related]
6. Complete brain-type creatine kinase deficiency in mice blocks seizure activity and affects intracellular calcium kinetics.
Streijger F; Scheenen WJ; van Luijtelaar G; Oerlemans F; Wieringa B; Van der Zee CE
Epilepsia; 2010 Jan; 51(1):79-88. PubMed ID: 19624717
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of creatine.
Beal MF
Amino Acids; 2011 May; 40(5):1305-13. PubMed ID: 21448659
[TBL] [Abstract][Full Text] [Related]
8. Presence of (phospho)creatine in developing and adult skeletal muscle of mice without mitochondrial and cytosolic muscle creatine kinase isoforms.
in 't Zandt HJ; de Groof AJ; Renema WK; Oerlemans FT; Klomp DW; Wieringa B; Heerschap A
J Physiol; 2003 May; 548(Pt 3):847-58. PubMed ID: 12640020
[TBL] [Abstract][Full Text] [Related]
9. Potential neuroprotective effect of t-butylhydroquinone against neurotoxicity-induced by 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-methyl-MPTP) in mice.
Abdel-Wahab MH
J Biochem Mol Toxicol; 2005; 19(1):32-41. PubMed ID: 15736157
[TBL] [Abstract][Full Text] [Related]
10. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
Kurosaki R; Muramatsu Y; Kato H; Watanabe Y; Imai Y; Itoyama Y; Araki T
Eur Neuropsychopharmacol; 2005 Jan; 15(1):57-67. PubMed ID: 15572274
[TBL] [Abstract][Full Text] [Related]
11. Promethazine protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.
Cleren C; Starkov AA; Calingasan NY; Lorenzo BJ; Chen J; Beal MF
Neurobiol Dis; 2005 Dec; 20(3):701-8. PubMed ID: 16126396
[TBL] [Abstract][Full Text] [Related]
12. Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTP neurotoxicity in mice.
Kato H; Kurosaki R; Oki C; Araki T
Brain Res; 2004 Dec; 1030(1):66-73. PubMed ID: 15567338
[TBL] [Abstract][Full Text] [Related]
13. Rifampicin attenuates the MPTP-induced neurotoxicity in mouse brain.
Oida Y; Kitaichi K; Nakayama H; Ito Y; Fujimoto Y; Shimazawa M; Nagai H; Hara H
Brain Res; 2006 Apr; 1082(1):196-204. PubMed ID: 16515773
[TBL] [Abstract][Full Text] [Related]
14. The novel cyclooxygenase-2 inhibitor GW637185X protects against l-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.
Aguirre JA; Leo G; Cueto R; Andbjer B; Naylor A; Medhurst AD; Agnati LF; Fuxe K
Neuroreport; 2008 Apr; 19(6):657-60. PubMed ID: 18382281
[TBL] [Abstract][Full Text] [Related]
15. Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced parkinsonism.
Anderson DW; Bradbury KA; Schneider JS
Eur J Neurosci; 2008 Aug; 28(3):610-7. PubMed ID: 18702732
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease.
Meuer K; Pitzer C; Teismann P; Krüger C; Göricke B; Laage R; Lingor P; Peters K; Schlachetzki JC; Kobayashi K; Dietz GP; Weber D; Ferger B; Schäbitz WR; Bach A; Schulz JB; Bähr M; Schneider A; Weishaupt JH
J Neurochem; 2006 May; 97(3):675-86. PubMed ID: 16573658
[TBL] [Abstract][Full Text] [Related]
17. Regulation of striatal preproenkephalin mRNA levels in MPTP-lesioned mice treated with estradiol.
D'Astous M; Morissette M; Callier S; Di Paolo T
J Neurosci Res; 2005 Apr; 80(1):138-44. PubMed ID: 15723346
[TBL] [Abstract][Full Text] [Related]
18. Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue.
Andres RH; Huber AW; Schlattner U; Pérez-Bouza A; Krebs SH; Seiler RW; Wallimann T; Widmer HR
Neuroscience; 2005; 133(3):701-13. PubMed ID: 15890457
[TBL] [Abstract][Full Text] [Related]
19. H MRS identifies lactate rise in the striatum of MPTP-treated C57BL/6 mice.
Koga K; Mori A; Ohashi S; Kurihara N; Kitagawa H; Ishikawa M; Mitsumoto Y; Nakai M
Eur J Neurosci; 2006 Feb; 23(4):1077-81. PubMed ID: 16519673
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.
Liu LX; Chen WF; Xie JX; Wong MS
Neurosci Res; 2008 Feb; 60(2):156-61. PubMed ID: 18054104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]